Skip to main content

Table 4 Associations between TACE-Iodine 125 treatment and mortality and recurrence in patients with early-intermediate HCC after PSM

From: Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma

Characteristics Mortality Recurrence
Adjusted HR (95%CI) P value Adjusted HR (95%CI) P value
Overall
TACE-RFA Reference   Reference  
TACE-Iodine 125 0.766 (0.384,1.530) 0.450 1.220 (0.711,2.093) 0.470
  1. Abbreviations: TACE Transarterial chemoembolization; RFA Radiofrequency ablation; BCLC Barcelona Clinic Liver Cancer